Work

Outcomes in patients with relapsed or refractory multiple myeloma in a phase I study of everolimus in combination with lenalidomide

Year: 2014

Type: article

Study design: Clinical Trial

Source: British Journal of Haematology

DOI: 10.1111/bjh.12909

Authors: Andrew J. Yee, Parameswaran Hari, Raffaella Marcheselli, Anuj K. Mahindra, Diana D. Cirstea, Tyler A. Scullen, Jill N. Burke, Scott J. Rodig, Teru Hideshima, Jacob P. Laubach, Irene M. Ghobrial, Robert L. Schlossman, Nikhil C. Munshi, Kenneth C. Anderson, Edie A. Weller, Paul G. Richardson, Noopur S. Raje

Institutions: Harvard University, Massachusetts General Hospital, Medical College of Wisconsin, Dana-Farber Cancer Institute, Brigham and Women's Hospital

Language: English

Topic: Multiple Myeloma Research and Treatments

Subfield: Hematology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: Celgene, National Institutes of Health, National Cancer Institute

Awards: Host-tumor cell interaction in myeloma: therapeutic applications, G4680808690, Integrative Oncogenomics of Multiple Myeloma

OpenAlex ID: W2003428294

FWCI: 3.67

Cites: 47

Cited by: 42

Related to: 10